ABOS Acumen Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$2,04
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,5052-Wochen-Tief
$3,6052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$148M
P/E
-1.2
EPS
$-2.00
Ihre Abzeichen
52W-Spanne
$2–$4
Analystenbewertung
STRONG BUY
Kursziel
$8
P/E
-1.2
ROE
-129.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ABOS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.04
Marktkapitalisierung (MRQ)
$148M
P/E
-1.2
EPS
$-2.00
ROE
-129.4%
Verschuldungsgrad (MRQ)
0.3
52W-Spanne
$2–$4
ABOS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-2.002021-12-31 → 2025-12-31
Freier Cashflow$-116M2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ABOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.25-Jahres-Durchschnitt ≈-2.4 | ≈-2.4 | · | · | |
| K/B (MRQ) | 2.65-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 2.5 | Überbewertet | |
| EV / EBITDA | -0.3 | · | · | · | |
| Kurs / FCF (TTM) | -1.65-Jahres-Durchschnitt ≈-5.8 | ≈-5.8 | · | · | |
| Kurs / Cashflow (TTM) | -1.65-Jahres-Durchschnitt ≈-5.8 | ≈-5.8 | · | · | |
| EV / FCF (TTM) | -0.6 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.15-Jahres-Durchschnitt ≈1.1 | ≈1.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ABOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -67.1%5-Jahres-Durchschnitt ≈-43.7% | ≈-43.7% | -56.4% | Schwach | |
| ROE | -129.4%5-Jahres-Durchschnitt ≈-53.2% | ≈-53.2% | -60.0% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ABOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.3 | · | 0.1 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 2.55-Jahres-Durchschnitt ≈13.2 | ≈13.2 | 9.2 | Geringe Liquidität | |
| Quick Ratio | 3.95-Jahres-Durchschnitt ≈8.7 | ≈8.7 | 7.8 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.6%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.45 | $-0.37 | -20.2% |
| 31. März 2026 | Mai 19, 2026 | $-0.33 | $-0.41 | 19.7% |
| 31. Dezember 2025 | $-0.41 | $-0.46 | 11.3% | |
| 30. September 2025 | $-0.44 | $-0.62 | 28.5% | |
| 30. Juni 2025 | $-0.68 | $-0.55 | -23.9% | |
| 31. März 2025 | $-0.48 | $-0.68 | 29.1% | |
| 31. Dezember 2024 | $-0.62 | $-0.49 | -26.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $105M | $94M | $42M | $32M | $12M | $8M | |
| SG&A Expense | $19M | $20M | $19M | $13M | $7M | $1M | |
| Operating Expenses | $124M | $114M | $61M | $45M | $20M | $9M | |
| Operating Income | $-124M | $-114M | $-61M | $-45M | $-20M | $-8M | |
| Interest Expense | · | · | $581.0K | $0 | · | · | |
| Interest Income | $7M | $14M | $11M | $2M | · | · | |
| Other Non-op | $-266.0K | $-151.0K | $-83.0K | $-11.0K | $51.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-121M | $-102M | $-52M | $-43M | $-101M | $-7M | |
| EPS (Basic) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| EPS (Diluted) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| Shares (Basic) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| Shares (Diluted) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| EBITDA | $-124M | $-114M | $-61M | $-45M | $-20M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $36M | $67M | $130M | $122M | $44M | |
| Short-term Investments | $63M | $136M | $177M | $48M | $72M | · | |
| Prepaid Expense | $5M | $7M | $3M | $3M | $4M | $543.0K | |
| Other Current Assets | · | · | $283.0K | $237.0K | $140.0K | · | |
| Current Assets | $122M | $178M | $247M | $180M | $199M | $44M | |
| PP&E (Net) | $103.0K | $73.0K | $122.0K | $165.0K | $36.0K | · | |
| Accum. Depreciation | $200.0K | $100.0K | $100.0K | · | · | · | |
| Other Non-current Assets | $350.0K | $486.0K | $724.0K | $151.0K | $14.0K | $0 | |
| Total Assets | $123M | $239M | $310M | $197M | $230M | $44M | |
| Accounts Payable | $554.0K | $6M | $1M | $2M | $1M | $531.0K | |
| Accrued Liabilities | $10M | $7M | $6M | $3M | · | · | |
| Short-term Debt | $9M | $0 | · | · | · | · | |
| Current Liabilities | $30M | $28M | $13M | $8M | $5M | · | |
| Capital Leases | · | $150.0K | $284.0K | $0 | · | · | |
| Other Non-current Liabilities | $0 | $150.0K | $284.0K | · | · | · | |
| Total Liabilities | $52M | $57M | $43M | $8M | $5M | $6M | |
| Long-term Debt | $22M | $29M | $30M | $0 | · | · | |
| Total Debt | $9M | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $517M | $507M | $489M | $360M | $353M | $8M | |
| Retained Earnings | $-446M | $-325M | $-223M | $-170M | $-128M | $-27M | |
| AOCI | $83.0K | $-48.0K | $312.0K | $-751.0K | · | · | |
| Stockholders' Equity | $70M | $182M | $267M | $189M | $225M | $-19M | |
| Liabilities + Equity | $123M | $239M | $310M | $197M | $230M | $44M | |
| Shares Outstanding | 60,575,369 | 60,094,083 | 57,910,461 | 41,025,062 | 40,473,270 | 419,124 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $6M | $3M | $922.0K | $154.0K | |
| Operating Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | $-7M | |
| CapEx | $88.0K | $16.0K | $21.0K | $161.0K | $40.0K | · | |
| Investing Cash Flow | $134M | $48M | $-172M | $39M | $-104M | · | |
| Stock Issued | $0 | $8M | $122M | $4M | $169M | · | |
| Net Stock Activity | $0 | $8M | $122M | $4M | $169M | · | |
| Financing Cash Flow | $-34.0K | $7M | $152M | $4M | $200M | $45M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.1% | -37.3% | -20.7% | -20.1% | -73.2% | · | |
| ROE | -129.4% | -51.3% | -19.1% | -22.2% | -43.9% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 6.5 | 19.0 | 23.1 | · | · | |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | |
| Interest Coverage | · | · | -105.2 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $3.03 | $4.61 | $4.60 | $5.56 | · | |
| Cash Flow / Share | $-1.91 | $-1.44 | $-0.89 | $-0.87 | · | · | |
| Cash / Share | $0.89 | $0.59 | $1.16 | · | $3.02 | · | |
| EPS (TTM) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | $-102M | $-52M | $-43M | $-101M | · | |
| Market Cap | $128M | $103M | $222M | $222M | $274M | · | |
| Enterprise Value | $20M | · | · | · | · | · | |
| P/E | -1.1 | -1.0 | -3.6 | -5.1 | -1.3 | · | |
| P/B | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Cash Flow | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| P / FCF | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| EV / EBITDA | -0.2 | · | · | · | · | · | |
| EV / FCF | -0.2 | · | · | · | · | · | |
| Earnings Yield | -94.8% | -99.4% | -28.1% | -19.6% | -74.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $16M | $21M | $22M | $37M | $25M | $35M | $27M | $20M | $12M | $13M | $11M | $9M | $9M | $11M | $8M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $33M | $21M | $25M | $27M | $42M | $30M | $40M | $32M | $24M | $18M | $18M | $16M | $13M | $13M | $14M | $11M | |
| Operating Income | $-33M | $-21M | $-25M | $-27M | $-42M | $-30M | $-40M | $-32M | $-24M | $-18M | $-18M | $-16M | $-13M | $-13M | $-14M | $-11M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $0 | · | · | |
| Interest Income | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | · | · | |
| Other Non-op | $-19.0K | $-43.0K | $-4.0K | $-69.0K | $-129.0K | $-64.0K | $-62.0K | $33.0K | $-68.0K | $-54.0K | $-21.0K | $-42.0K | $-16.0K | $-4.0K | $-10.0K | $-2.0K | |
| Net Income | $-33M | $-21M | $-25M | $-26M | $-41M | $-29M | $-37M | $-30M | $-21M | $-15M | $-16M | $-13M | $-12M | $-11M | $-13M | $-11M | |
| EPS (Basic) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| EPS (Diluted) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| Shares (Basic) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| Shares (Diluted) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| EBITDA | $-33M | $-21M | · | $-27M | $-42M | $-30M | · | $-32M | $-24M | $-18M | · | $-16M | $-13M | $-13M | · | $-11M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $59M | $52M | $54M | $47M | $37M | $30M | $36M | $33M | $68M | $47M | $67M | $95M | · | · | $130M | $158M | |
| Short-term Investments | $51M | $77M | $63M | $80M | $107M | $119M | $136M | $167M | $193M | $206M | $177M | $121M | $68M | $62M | $48M | $43M | |
| Prepaid Expense | $5M | $5M | $5M | $6M | $5M | $6M | $7M | $7M | $6M | $3M | $3M | $3M | $5M | $4M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | $457.0K | $405.0K | $395.0K | · | $181.0K | $208.0K | $294.0K | $237.0K | · | |
| Current Assets | $116M | $133M | $122M | $132M | $148M | $155M | $178M | $208M | $267M | $256M | $247M | $219M | $150M | $144M | $180M | $203M | |
| PP&E (Net) | $80.0K | $91.0K | $103.0K | $115.0K | $130.0K | $137.0K | $73.0K | $89.0K | $105.0K | $117.0K | $122.0K | $123.0K | $136.0K | $151.0K | · | $142.0K | |
| Accum. Depreciation | $100.0K | $200.0K | $200.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | · | · | $100.0K | · | · | · | · | · | |
| Other Non-current Assets | $263.0K | $304.0K | $350.0K | $393.0K | $464.0K | $504.0K | $486.0K | $170.0K | $425.0K | $324.0K | $724.0K | $189.0K | $208.0K | $195.0K | $151.0K | $92.0K | |
| Total Assets | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Accounts Payable | $13M | $2M | $554.0K | $682.0K | $2M | $1M | $6M | $2M | $4M | $3M | $1M | $1M | $2M | $762.0K | $2M | $2M | |
| Accrued Liabilities | $8M | $5M | $10M | $8M | $12M | $7M | $7M | $5M | $4M | $3M | $6M | $3M | $2M | · | $3M | · | |
| Short-term Debt | $20M | $14M | $9M | $4M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $47M | $29M | $30M | $22M | $25M | $19M | $28M | $20M | $15M | $8M | $13M | $6M | $9M | $9M | $8M | $7M | |
| Capital Leases | · | · | · | $39.0K | $77.0K | $114.0K | $150.0K | $185.0K | $219.0K | $252.0K | $284.0K | · | · | · | $0 | · | |
| Other Non-current Liabilities | · | · | $0 | $39.0K | $77.0K | $114.0K | $150.0K | · | · | · | $284.0K | · | · | · | · | · | |
| Total Liabilities | $59M | $46M | $52M | $49M | $55M | $49M | $57M | $50M | $45M | $39M | $43M | $6M | $9M | $9M | $8M | $7M | |
| Long-term Debt | $12M | $17M | $22M | $27M | $30M | $30M | $29M | $30M | $29M | $30M | $30M | · | · | · | $0 | · | |
| Total Debt | $20M | $14M | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $557M | $555M | $517M | $514M | $512M | $509M | $507M | $505M | $502M | $500M | $489M | $487M | $363M | $361M | $360M | $355M | |
| Retained Earnings | $-500M | $-467M | $-446M | $-421M | $-395M | $-354M | $-325M | $-288M | $-258M | $-238M | $-223M | $-206M | $-193M | $-182M | $-170M | $-158M | |
| AOCI | $-13.0K | $21.0K | $83.0K | $109.0K | $23.0K | $15.0K | $-48.0K | $518.0K | $-164.0K | $-144.0K | $312.0K | $-509.0K | $-646.0K | · | $-751.0K | · | |
| Stockholders' Equity | $57M | $87M | $70M | $93M | $117M | $156M | $182M | $217M | $244M | $262M | $267M | $280M | $169M | $179M | $189M | $197M | |
| Liabilities + Equity | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Shares Outstanding | 72,314,714 | 72,227,580 | 60,575,369 | 60,573,425 | 60,573,425 | 60,573,425 | 60,094,083 | 60,079,778 | 60,079,778 | 60,079,778 | 57,910,461 | 57,910,461 | 41,025,062 | 41,025,062 | 41,025,062 | 40,503,124 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $888.0K | $840.0K | |
| Operating Cash Flow | $-18M | $-24M | $-19M | $-30M | $-32M | $-34M | $-27M | $-25M | $-17M | $-18M | $-8M | $-13M | $-12M | $-10M | $-11M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $9.0K | $79.0K | $0 | $0 | $5.0K | $11.0K | $14.0K | $7.0K | $0 | $0 | $35.0K | $81.0K | |
| Investing Cash Flow | $26M | $-14M | $26M | $41M | $38M | $29M | $30M | $-10M | $38M | $-9M | $-49M | $-92M | $11M | $-42M | $-20M | $56M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8M | $-390.0K | $122M | $0 | $0 | $4M | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $8M | · | · | · | · | · | · | |
| Financing Cash Flow | $-278.0K | $36M | $2.0K | $0 | $0 | $-36.0K | $-9.0K | $-42.0K | $-128.0K | $7M | $29M | $123M | $-145.0K | $0 | $4M | $-263.0K | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | $-24M | · | · | · | $-34M | · | · | · | $-18M | · | · | · | $-10M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.7% | -12.3% | · | -12.9% | -17.8% | -11.4% | · | -10.8% | -8.8% | -6.1% | · | -5.3% | -6.0% | -5.5% | · | -4.9% | |
| ROE | -37.5% | -17.1% | · | -17.0% | -22.7% | -13.8% | · | -12.0% | -10.0% | -6.7% | · | -5.4% | -6.2% | -5.7% | · | -5.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 4.6 | · | 6.0 | 6.0 | 8.0 | · | 10.4 | 17.4 | 30.2 | · | 35.8 | 17.5 | 16.4 | · | 30.6 | |
| Quick Ratio | 2.4 | 4.4 | · | 5.8 | 5.8 | 7.7 | · | 10.1 | 17.0 | 29.8 | · | 35.3 | 7.9 | 7.1 | · | 30.3 | |
| Debt / Equity | 0.3 | 0.2 | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.8 | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.79 | $1.21 | · | $1.54 | $1.93 | $2.57 | · | $3.62 | $4.06 | $4.36 | · | $4.84 | $4.12 | $4.37 | · | $4.86 | |
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.56 | · | · | · | $-0.30 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $0.82 | $0.72 | · | $0.77 | $0.61 | $0.50 | · | $0.55 | $1.13 | $0.78 | · | $1.64 | · | · | · | $3.89 | |
| EPS (TTM) | $-1.62 | $-1.85 | · | $-2.22 | $-2.28 | $-1.94 | · | $-1.37 | $-1.11 | $-1.05 | · | $-1.12 | $-1.14 | $-1.11 | · | $1.24 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-105M | $-113M | · | $-133M | $-137M | $-116M | · | $-82M | $-65M | $-56M | · | $-49M | $-46M | $-45M | · | $-38M | |
| Market Cap | $193M | $170M | · | $104M | $70M | $67M | · | $149M | $145M | $243M | · | $240M | $197M | $167M | · | $406M | |
| Enterprise Value | $103M | $56M | · | $-19M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.6 | -1.3 | · | -0.8 | -0.5 | -0.6 | · | -1.8 | -2.2 | -3.9 | · | -3.7 | -4.2 | -3.7 | · | 8.1 | |
| P/B | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Tangible Book | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Cash Flow | · | -7.1 | · | · | · | -2.0 | · | · | · | -13.6 | · | · | · | -16.4 | · | · | |
| Earnings Yield | -60.7% | -78.4% | · | -129.8% | -196.6% | -176.4% | · | -55.2% | -45.9% | -25.9% | · | -27.0% | -23.7% | -27.3% | · | 12.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-121M | $-102M | $-52M | $-43M | $-101M |
| Verwässerte EPS | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | · | · | · | · |
| Liquiditätsgrad | 4.1 | 6.5 | 19.0 | 23.1 | · |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-116M | $-86M | $-43M | $-35M | $-18M |
Institutionelle Eigentümer (13F) 102 Einreicher · $131.5M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
102
Gehaltener Wert
$131.5M
Neue Positionen
30
Geschlossene Positionen
17
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 30 (+4 vs. Vorquartal) | 17 (+12 vs. Vorquartal) | 22 (-9 vs. Vorquartal) | 15 (+3 vs. Vorquartal) | +1.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $56.050.426 | 20.992.669 | 42,62% | Aktien |
| Sands Capital Alternatives, LLC | $9.932.680 | 3.720.105 | 7,55% | Aktien |
| BlackRock, Inc. | $6.648.607 | 2.490.115 | 5,05% | Aktien |
| Alyeska Investment Group, L.P. | $6.554.193 | 2.454.754 | 4,98% | Aktien |
| FRANKLIN RESOURCES INC | $6.154.606 | 2.305.096 | 4,68% | Aktien |
| ADAR1 Capital Management, LLC | $5.637.262 | 2.111.334 | 4,29% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.464.432 | 1.672.072 | 3,39% | Aktien |
| Knollwood Investment Advisory, LLC | $4.348.122 | 1.628.510 | 3,31% | Aktien |
| VANGUARD GROUP INC | $3.489.459 | 1.653.772 | 2,65% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.049.286 | 1.141.858 | 2,32% | Aktien |
| Ikarian Capital, LLC | $2.813.638 | 1.053.797 | 2,14% | Aktien |
| Hudson Bay Capital Management LP | $2.549.850 | 955.000 | 1,94% | Aktien |
| Pathstone Holdings, LLC | $2.293.824 | 859.110 | 1,74% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.802.317 | 675.025 | 1,37% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.663.095 | 622.882 | 1,26% | Aktien |
| STATE STREET CORP | $1.603.410 | 600.528 | 1,22% | Aktien |
| NORTHERN TRUST CORP | $963.187 | 360.744 | 0,73% | Aktien |
| TWO SIGMA ADVISERS, LP | $889.998 | 421.800 | 0,68% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $856.523 | 320.795 | 0,65% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $778.969 | 291.559 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $777.611 | 291.240 | 0,59% | Aktien |
| BANK OF AMERICA CORP /DE/ | $733.665 | 274.781 | 0,56% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $728.942 | 273.012 | 0,55% | Aktien |
| NOMURA HOLDINGS INC | $506.531 | 189.712 | 0,39% | Aktien |
| GOLDMAN SACHS GROUP INC | $491.085 | 183.927 | 0,37% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $470.377 | 176.171 | 0,36% | Aktien |
| MORGAN STANLEY | $365.157 | 136.763 | 0,28% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $336.698 | 126.104 | 0,26% | Aktien |
| Bank of New York Mellon Corp | $332.086 | 124.377 | 0,25% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $307.314 | 115.099 | 0,23% | Aktien |
| PFG Investments, LLC | $251.648 | 94.250 | 0,19% | Aktien |
| CATALYST FINANCIAL PARTNERS LLC | $239.496 | 89.699 | 0,18% | Aktien |
| Nuveen, LLC | $169.158 | 63.355 | 0,13% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $161.797 | 60.598 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $158.598 | 59.400 | 0,12% | Kaufoption |
| Squarepoint Ops LLC | $139.777 | 52.351 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $136.301 | 51.049 | 0,10% | Aktien |
| Prospera Financial Services Inc | $133.500 | 50.000 | 0,10% | Aktien |
| WELLS FARGO & COMPANY/MN | $132.661 | 49.686 | 0,10% | Aktien |
| MARSHALL WACE, LLP | $128.465 | 48.114 | 0,10% | Aktien |
| DEUTSCHE BANK AG\ | $123.172 | 46.132 | 0,09% | Aktien |
| Verdad Advisers, LP | $118.756 | 44.478 | 0,09% | Aktien |
| BARCLAYS PLC | $105.878 | 39.655 | 0,08% | Aktien |
| Qube Research & Technologies Ltd | $103.099 | 38.614 | 0,08% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $96.654 | 36.200 | 0,07% | Aktien |
| RHUMBLINE ADVISERS | $93.535 | 35.034 | 0,07% | Aktien |
| Rangeley Capital, LLC | $93.450 | 35.000 | 0,07% | Aktien |
| XTX Topco Ltd | $85.798 | 32.134 | 0,07% | Aktien |
| Intrepid Financial Planning Group LLC | $80.501 | 30.150 | 0,06% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $78.872 | 29.540 | 0,06% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 Einreichungen | 17. März 2026 | 29,50% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 17 Insider · 7 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Joseph Oconnell | Chief Executive Officer | 22. Januar 2026 S | 881.275 | 0 | 8 | $-163.230 |
| Matt Zuga | CFO & Chief Business Officer | 22. Januar 2026 S | 304.924 | 0 | 7 | $-49.630 |
| James J. Doherty | President and CDO | 16. Januar 2026 A | 220.900 | 0 | 2 | $-15.153 |
| Russell Barton | Chief Operating Officer | 22. Januar 2026 S | 205.092 | 0 | 6 | $-29.956 |
| Derek M Meisner | Chief Legal Officer & Corp Sec | 6. März 2026 M | 173.999 | 0 | 16 | $-248.780 |
| Eric Siemers | Chief Medical Officer | 22. Januar 2026 S | 255.371 | 0 | 4 | $-27.128 |
| Amy Schacterle | Chief Regulatory Officer | 16. Januar 2026 A | 92.303 | 0 | 1 | $-2.172 |
| Derrell Porter | Direktor | 17. Juni 2026 M | 35.500 | 0 | 3 | $-75.388 |
| Nathan B Fountain | Direktor | 9. Juni 2026 S | 48.150 | 0 | 1 | $-14.272 |
| Laura Stoppel | Direktor | 3. Juni 2026 A | 48.300 | 0 | 0 | $0 |
| John A Stalfort III | Direktor | 3. Juni 2026 A | 220.624 | 0 | 0 | $0 |
| Jeffrey L. Ives | Direktor | 3. Juni 2026 A | 48.300 | 0 | 0 | $0 |
| George Golumbeski | Direktor | 3. Juni 2026 A | 35.500 | 0 | 0 | $0 |
| Kimberlee C Drapkin | Direktor | 3. Juni 2026 A | 48.300 | 0 | 0 | $0 |
| Jeffrey Sevigny | Direktor | 15. Juni 2022 A | · | 0 | 0 | $0 |
| Robert D. Hardie | 10%-Eigentümer | 6. Juli 2021 C | 657.985 | 0 | 0 | $0 |
| Paul B Manning | 10%-Eigentümer | 6. Juli 2021 C | 657.985 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 14 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,19% | 5.024 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 157.585 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 41.102 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 1.017.131 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 22.560 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4.079 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 100.013 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 7.149 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 513.511 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.118.322 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 273.215 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.478 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 9.637 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 427.467 SH | 11. September 2026 | Täglich |
ABOS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
KAUF
Median-Ziel
$8.00
+292,2%
6 50,0%
Starker Kauf
5 41,7%
Kauf
1 8,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-10-02Mittelwert-Ziel $7.60 +272,5%
← Unter allen Zielen
Aktueller Preis $2.04
Tief$5.00
Mittelwert$7.60
Hoch$10.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| HUMA | · | · | · | · | · | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026